Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hepatitis C Virus Envelope Protein E2 - Overview
Hepatitis C Virus Envelope Protein E2 - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Hepatitis C Virus Envelope Protein E2 - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Hepatitis C Virus Envelope Protein E2 - Companies Involved in Therapeutics Development
Enid Therapeutics LLC
Integrated BioTherapeutics Inc
Toray Industries Inc
Uvax Bio LLC
Hepatitis C Virus Envelope Protein E2 - Drug Profiles
CIGB-230 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis C (strain H77) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis C vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis C vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis C vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis C vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibodies to Inhibit E2 Glycoprotein for HCV - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibodies to Target Viral E1 and E2 Proteins for Hepatitis C - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibody to Inhibit E1 and E2 Glycoprotein for Hepatitis C - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptides to Inhibit E1 and E2 Glycoprotein for HCV - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Hepatitis C Virus Envelope Protein E2 - Dormant Products
Hepatitis C Virus Envelope Protein E2 - Discontinued Products
Hepatitis C Virus Envelope Protein E2 - Product Development Milestones
Featured News & Press Releases
Jun 10, 2013: IBT and Stanford Awarded STTR
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development by Stage of Development, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Indication, 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products under Investigation by Universities/Institutes, 2021
Products under Investigation by Universities/Institutes, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Pipeline by Ennaid Therapeutics LLC, 2021
Pipeline by Integrated BioTherapeutics Inc, 2021
Pipeline by Toray Industries Inc, 2021
Pipeline by Uvax Bio LLC, 2021
Dormant Projects, 2021
Discontinued Products, 2021